| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $16.84 ▼ -4.48% | Yesterday | $15.97 ▲ +10.39% | Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $17.63 and targets $16.84 (-4.48%). The near-term read is downside; watch $20.00 / $17.28 because daily realized volatility is about 7.01%. |
Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $17.63 and targets $16.84 (-4.48%). The near-term read is downside; watch $20.00 / $17.28 because daily realized volatility is about 7.01%. | ||||
| Week | $15.89 ▼ -9.87% | Last Week | $17.43 ▲ +1.15% | The 7-day Viridian Therapeutics Inc. Common Stock model moves from $17.43 to $15.89 (-9.87%). It gives downside momentum context for this stock, so breaks around $20.00 / $17.28 matter more than a single tick. |
The 7-day Viridian Therapeutics Inc. Common Stock model moves from $17.43 to $15.89 (-9.87%). It gives downside momentum context for this stock, so breaks around $20.00 / $17.28 matter more than a single tick. | ||||
| Month | $15.64 ▼ -11.29% | Last Month | $14.28 ▲ +23.46% | The 1-month Viridian Therapeutics Inc. Common Stock target is $15.64 (-11.29%), compared with the live reference near $17.63. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Viridian Therapeutics Inc. Common Stock target is $15.64 (-11.29%), compared with the live reference near $17.63. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $16.26 ▼ -7.77% | Last Year | $13.66 ▲ +29.06% | The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.26 (-7.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.26 (-7.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $18.26 ▲ +3.57% | 5 Years Ago | $17.75 ▼ -0.68% | The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+3.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+3.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 53.8 | Neutral |
| MACD | -0.10 | Bearish |
| SMA 50 | $16.57 | Mid |
| SMA 200 | $16.12 | Mid |
| EMA 20 | $16.38 | Mid |
| Opening Price | $16.00 | Start Date | 2020-01-02 |
| Day Range | $15.99 – $17.73 | Market Cap | $1.47B |
| Monthly Range | $13.30 – $18.75 | 24h Volume | n/a |
| 90D Range | $13.30 – $33.78 | Circulating | n/a |
| 52W Range | $11.02 – $33.78 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.